Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the ...

Studies have shown that individuals using semaglutide can achieve an average weight loss of 15-20% when combined with a healthy diet and regular exercise. This remarkable efficacy sets GetSimpli ...

The average American woman weighs ... your overall health and achieving your weight goals. Regular exercise helps you burn extra calories, lose weight loss, and put on muscle.

Heavy drinkers who were ­taking weight-loss jabs in a Dublin clinic significantly reduced their ­alcohol intake down from 12 to four pints a week, according to a new study. The research was ...